[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 2,416
Citations 0
Clinical Trials Update
September 26, 2017

Prophylactic Low-Dose Aspirin Reduces Risk of Preterm Preeclampsia

JAMA. 2017;318(12):1099. doi:10.1001/jama.2017.13073

Women at high risk of preterm preeclampsia who took low-dose aspirin during their pregnancy had a significantly lower incidence of the disease compared with a placebo group, found a trial in the New England Journal of Medicine.

The 1776 women with singleton pregnancies deemed to be at high risk of preterm preeclampsia based on a unique multimodal screening tool were randomly assigned to receive aspirin (150 mg/d) or placebo from 11 to 14 weeks of gestation until 36 weeks of gestation.